Livsmed Inc (KOSDAQ:491000)

Livsmed Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	16,443	11,402	16,815	8,019	14,911
Short-Term Investments	100,015	120,000	-	32,000	-
Cash & Short-Term Investments	116,458	131,402	16,815	40,019	14,911
Cash Growth	592.57%	681.44%	-57.98%	168.39%	-
Accounts Receivable	32,159	31,457	14,644	7,722	3,937
Other Receivables	1,202	201.39	72	356.21	159.98
Receivables	33,410	31,706	14,764	8,126	4,145
Inventory	14,182	9,768	4,283	3,793	2,926
Prepaid Expenses	-	406.9	224.3	128.67	79.28
Other Current Assets	3,452	1,567	1,534	570.45	114.74
Total Current Assets	167,501	174,850	37,620	52,638	22,176
Property, Plant & Equipment	25,042	22,305	11,763	5,142	3,668
Long-Term Investments	-	0	0	-	-0
Other Intangible Assets	1,985	1,698	1,079	846.07	742.94
Other Long-Term Assets	3,320	3,080	2,796	1,211	675.37
Total Assets	197,847	201,933	53,258	60,396	27,821

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Accounts Payable	-	2,489	1,290	1,326	848.48
Accrued Expenses	-	1,160	555.34	292.5	308.04
Short-Term Debt	3,000	3,000	3,000	3,000	4,900
Current Portion of Leases	1,633	1,497	1,037	573.91	563.48
Other Current Liabilities	10,611	5,648	3,056	142,199	177,043
Total Current Liabilities	15,244	13,794	8,938	147,392	183,663
Long-Term Leases	7,669	7,111	4,442	1,641	1,761
Pension & Post-Retirement Benefits	-	-	-	-	1,877
Other Long-Term Liabilities	144.78	159.49	274.36	332.66	598.46
Total Liabilities	23,058	21,064	13,654	149,365	187,899

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Common Stock	12,477	12,341	10,723	8,281	65.1
Additional Paid-In Capital	449,823	446,662	289,165	113,029	1,522
Retained Earnings	-301,780	-295,902	-273,028	-247,443	-190,266
Comprehensive Income & Other	14,270	17,768	12,744	9,003	4,936
Total Common Equity	174,790	180,869	39,604	-117,131	-183,743
Shareholders' Equity	174,790	180,869	39,604	-88,969	-160,079
Total Liabilities & Equity	197,847	201,933	53,258	60,396	27,821

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Total Debt	12,302	11,607	8,479	5,214	7,225
Net Cash (Debt)	104,156	119,795	8,336	34,804	7,686
Net Cash Growth	1149.40%	1337.00%	-76.05%	352.82%	-
Net Cash Per Share	4542.67	5394.74	498.85	2456.31	598.79
Filing Date Shares Outstanding	24.95	24.68	21.45	16.56	12.84
Total Common Shares Outstanding	24.95	24.68	21.45	16.56	12.84
Working Capital	152,257	161,056	28,682	-94,754	-161,487
Book Value Per Share	7004.66	7328.07	1846.69	-7072.26	-14314.72
Tangible Book Value	172,805	179,171	38,524	-117,977	-184,486
Tangible Book Value Per Share	6925.12	7259.28	1796.38	-7123.35	-14372.60
Land	733	733	733	733	-
Buildings	351.93	351.93	351.93	351.93	-
Machinery	8,211	7,420	5,429	2,734	1,780
Construction In Progress	5,753	4,139	1,179	43.08	14.01

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error